Bomedemstat (IMG-7289/MK-3543)

bomedemstat · Imago BioSciences, Inc. (subsidiary of Merck & Co., Inc.)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bomedemstat (IMG-7289/MK-3543), covering 2023-07-11 to 2023-07-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001) [Phase 1, Phase 2]

See pricing